SCHEMBL1776873

SCHEMBL1776873

COc1cccc(S(=O)(=O)c2cc3c(N4CCNCC4)nccc3s2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 11/20 0.57
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
USP2 O75604 1/20 0.46
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
ADRB1 P08588 1/20 0.43
HTR2C P28335 1/20 0.42
NCF1 P14598 1/20 0.41
TP53 P04637 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
HTR1A P08908 1/20 0.41
DRD2 P14416 1/20 0.41
HTR2A P28223 1/20 0.41
HTR7 P34969 1/20 0.41
GUSB P08236 1/20 0.41
ERBB2 P04626 1/20 0.40
PTK6 Q13882 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1774370 0.99 HTR6 (0.56) HTR6CYP1A2CYP3A4USP2CYP2C19
SCHEMBL1775410 0.89 HTR6 (0.48) HTR6CYP1A2CYP3A4USP2CYP2C19
Hydrochloric Acid SCHEMBL1776185 0.88 HTR6 (0.47) HTR6CYP1A2CYP3A4USP2CYP2C19
SCHEMBL1775605 0.86 HTR6 (0.56) HTR6HTR2CHTR1ADRD2HTR2A
Hydrochloric Acid SCHEMBL1775612 0.85 HTR6 (0.55) HTR6HTR2CHTR1ADRD2HTR2A
Hydrochloric Acid SCHEMBL5013081 0.84 HTR6 (0.54) HTR6CYP1A2CYP3A4CYP2C19ADRB1
SCHEMBL1774912 0.84 HTR6 (0.43) HTR6CYP1A2CYP3A4USP2CYP2C19
Hydrochloric Acid SCHEMBL1774669 0.83 HTR6 (0.42) HTR6CYP1A2CYP3A4USP2CYP2C19
SCHEMBL1777100 0.82 HTR6 (0.46) HTR6CYP1A2CYP3A4USP2CYP2C19
SCHEMBL1775896 0.82 HTR6 (0.53) HTR6HTR2CHTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943639-B2 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss PROXIMAGEN LIMITED (GB) 2011-05-17 US claimed
EP-1513828-A1 NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS Biovitrum AB (SE) 2005-03-16 EP disclosed
WO-2004000828-A1 NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS BIOVITRUM AB (SE) 2003-12-31 WO disclosed